ZeroBounce today announced the relaunch of its email validation and deliverability platform. ZeroBounce 2.0 will offer faster, more accurate email validation tools and increased security features on a seamless, intuiti…
General Communication Equipment Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032 The Business Research Company’s General Communication Equipment Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032 The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and…
Pivotal acquisition in Envision Pharma Group’s tech-enabled offerings provides clients with access to advanced AI to accelerate decision-making that optimizes their products’ path to market and ultimately supports the delivery of enhanced patient outcomes.
PHILADELPHIA, February 7, 2023 (Newswire.com)
–
Envision Pharma Group (Envision), a leading global technology-enabled commercialization, integrated medical capabilities and solutions, and data analytics partner to the life sciences industry, announced today it has acquired OKRA.ai, an award-winning technology company active in the provision of artificial intelligence (AI) solutions with present brains across commercialization, real-world evidence and data analytics, medical, and pricing for the pharmaceutical and life sciences industry.
OKRA.ai’s AI products and solutions translate large clinical, scientific, and commercial data sets into actionable insights to empower decision-making and drive action to clients in the life sciences industry.
“We are delighted to welcome OKRA.ai into the Envision Pharma Group family,” shares Meg Heim, CEO, Envision Pharma Group. “The acquisition of OKRA.ai marks an exciting milestone in Envision’s evolution as we continue to accelerate and deliver a compelling combination of technology-enabled capabilities and solutions to clients. The combination of Envision’s leading technology, capabilities, and solutions with OKRA.ai’s artificial intelligence solutions and expertise enables us to strengthen our offerings to clients across the product life cycle, but more importantly, support patients in their journey to health and wellness.”
Dr. Loubna Bouarfa, founder of OKRA.ai, will be joining Envision as a member of its Executive Leadership Team. Recently, Loubna won the prestigious Deloitte Fast 50 Women in Leadership Award and Forbes 50 Top Women in Tech. Loubna shares, “Today is a redefining moment for OKRA.ai. I am honored to be joining forces with Envision and see enormous opportunities for the growth of our combined expertise and solutions for clients in the life sciences industry. As part of Envision Pharma Group, we can accelerate our work to bring AI to the heart of decision-making across the life sciences industry. Our success will not only bring commercial benefit to clients but lead to improved patient outcomes across the globe.”
Based in the U.K. and Netherlands, OKRA.ai employs around 30 members of staff. The acquisition of OKRA.ai will bring the total number of Envision Pharma Group to 1,400+ employees across four continents.
About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product lifecycle through a comprehensive suite of services and industry-leading technology solutions: including evidence-based scientific communications and engagement; commercialization and integrated medical consultancy; and HEOR/market access and data analytics capabilities. Learn more at www.envisionpharmagroup.com
About OKRA.ai
OKRA.ai is a pioneer in developing AI solutions for the life sciences industry, bringing self-learning AI to optimize commercial, medical and market access decision making. Through its product portfolio, OKRA.ai delivers AI solutions to empower pharmaceutical companies with predictions and suggestions to bring novel treatments to patients in an efficient and effective way.
OKRA.ai was founded by Dr. Loubna Bouarfa in 2015 with a vision of moving the healthcare industry towards data-driven decision-making by explainable AI. Since then, OKRA.ai has been instrumental in building industry-first Explainable AI which empowers users by providing explanations behind predictions and suggestions. OKRA.ai currently consists of a highly qualified workforce across the UK and the Netherlands and has a nearly equal gender balance (48% of staff are female).
OKRA.ai’s solution suite compiles healthcare data from multiple sources, with coverage across hundreds of therapeutic areas, thousands of clinical trials and publications, millions of medically relevant free text and billions of data points that are specific to patient demographics. Since 2015, OKRA.ai has supported the commercialization of 92 molecules, 67 indications and 13 pharmaceutical brands.
Contact Information:
Colleen Carter
Communications
1 (203) 480 0080
Original Source:
Envision Pharma Group Acquires OKRA.ai
Under Secretary of State for Civilian Security, Democracy, and Human Rights Uzra Zeya will travel to Ulaanbaatar, Mongolia and Tokyo, Japan February 5-10, 2023. In Mongolia February 5-8, Under Secretary Zeya will meet with a range of government, civil society, and religious leaders to deepen robust U.S.-Mongolia partnership on democracy, human rights, law enforcement, and […]
The United States is announcing today two new security assistance packages to help Ukraine continue to defend itself against Russia’s brutal war. These packages include critical air defense and counter-drone capabilities to help Ukraine defend its people, as well as armored infantry vehicles and more equipment that Ukraine is using so effectively, including Javelin anti-tank […]
TV Ears expands blog, bringing important information to those struggling to watch TV with hearing difficulties
TV Ears TV Ears
…
Assistant Secretary of State for International Organization Affairs Michele Sison will travel to Seattle, Washington, February 6-7, 2023, to highlight America’s multilateral leadership and to discuss the many ways in which that leadership reflects U.S. values of democracy and human rights and contributes to our country’s safety, security, and prosperity. During her visit, the Assistant […]
MILWAUKEE, February 6, 2023 (Newswire.com)
–
The shop, located on the corner of Kinnickinnic Ave. and Ward Street, right across from Zilman Park, will be the …
The following joint statement was released by the Governments of the United States and Indonesia, co-chairs for the 3rd ASEAN-U.S. Cyber Policy Dialogue. Begin Text: The third ASEAN-U.S. Cyber Policy Dialogue was held virtually on February 1, 2023. The Dialogue demonstrated strong partnership and a shared vision of an open, peaceful, interoperable, reliable, and secure cyberspace that supports international trade […]
Does the world know everything about the notorious Jennifer Lopez? It turns out there are still a few stories left to tell! The beloved entertainer recently gave an exclusive interview to Ari Global, which is now available on Gossip Stone TV. This celebrity reality channel broadcasts on Amazon Fire TV, Roku TV, and Apple TV—and […]
